IBS and Gut Inflammation: What Your Digestive System Is Actually Reacting To

If you've been told you have IBS and that there's nothing structurally wrong — and you've been sent home with dietary advice and a prescription for antispasmodics — you're not alone. And the experience is frustrating, because the symptoms are very real. What that consultation may have missed is this: IBS and gut inflammation are not separate stories. Modern gastroenterological research has consistently found evidence of low-grade mucosal inflammation, altered gut microbiome composition, increased intestinal permeability, and dysregulated gut-brain signalling in the majority of IBS cases. This blog is a thorough look at what's actually happening inside the gut in IBS — the mechanisms, the triggers, and why understanding them changes everything about how you approach recovery.

Table of Contents

• 1. IBS and Gut Inflammation: What Your Digestive System Is Actually Reacting To
• 2. What IBS Actually Is — Rethinking the “Functional” Label
• 3. The Gut Microbiome — Where IBS Often Begins
• 4. Intestinal Permeability — Leaky Gut and the IBS Inflammatory Cycle
• 5. Mast Cells — The Immune Cells at the Heart of IBS Pain
• 6. Serotonin and the Gut — The Neurotransmitter Behind Motility and Pain
• 7. The Gut-Brain Axis in IBS — Why Stress, Anxiety, and IBS Always Appear Together
• 8. Food Triggers in IBS — What the Gut Is Actually Reacting To
• 9. FAQs
• 10. Conclusion

Key Benefits

• What IBS Actually Is — Rethinking the "Functional" Label
• "Functional disorder" has historically implied no identifiable structural disease — a label that has unfortunately been misread as meaning the symptoms are imaginary or exaggerated. The reality is that IBS involves measurable changes in gut physiology that standard colonoscopy and blood tests don't detect — but that are visible in gut biopsy, microbiome sequencing, and motility studies.
• Current research supports IBS as a disorder of gut-brain interaction — formerly called a functional GI disorder — characterised by:• Altered gut motility (either accelerated, slowed, or erratic)• Visceral hypersensitivity (the gut's pain threshold is abnormally low)• Dysregulated serotonin signalling in the enteric nervous system• Low-grade mucosal inflammation• Gut microbiome dysbiosis• Increased intestinal permeability
• The distinction from IBD (Crohn's disease and ulcerative colitis) is one of degree and pattern — not of whether inflammation is present. IBS and gut inflammation coexist, with IBS showing a subtler but still clinically significant inflammatory state.

The Gut Microbiome — Where IBS Often Begins

Disruption of the gut microbiome — gut dysbiosis — is one of the most reliably documented findings in IBS patients, and increasingly understood as a primary driver rather than a secondary consequence.

Studies using 16S ribosomal RNA sequencing have found that IBS patients show:• Reduced overall microbiome diversity (a consistent marker of gut disease risk)• Reduced populations of Bifidobacterium and Lactobacillus species• Overgrowth of gas-producing bacteria (particularly in IBS-D and IBS-C subtypes)• Altered ratios of Firmicutes to Bacteroidetes (associated with motility changes)• In a subset, small intestinal bacterial overgrowth (SIBO)

These microbial shifts produce clinical consequences through several pathways: excess gas production causing distension and pain; reduced short-chain fatty acid (SCFA) output weakening the gut lining and reducing mucosal immune function; and altered bile acid metabolism changing bowel transit speed.

Post-infectious IBS — which develops after a documented gastrointestinal infection (gastroenteritis) — is the clearest model of how microbiome disruption from a defined event triggers persistent IBS symptoms. Studies show 10–25% of people develop IBS following acute gastroenteritis, with altered microbiome composition persisting for months to years.

Intestinal Permeability — Leaky Gut and the IBS Inflammatory Cycle Increased intestinal permeability — commonly called leaky gut — refers to the loosening of tight junctions between intestinal epithelial cells, allowing bacterial fragments, food antigens, and endotoxins (LPS) to cross into the bloodstream and lamina propria. In IBS, studies have consistently found elevated zonulin (a protein that regulates tight junction opening), increased paracellular permeability in jejunal and colonic biopsies, and evidence of systemic immune activation from gut-derived LPS. This creates a cycle:1. Dysbiosis and psychological stress loosen tight junctions2. Bacterial LPS and food antigens cross the gut barrier3. The mucosal immune system activates — mast cells, T-cells, and macrophages release inflammatory mediators4. These mediators sensitise enteric nerves and alter motility5. Visceral hypersensitivity and altered transit develop6. Pain, urgency, bloating, and erratic bowel habits result Stress is a significant driver of this cycle — cortisol directly loosens tight junctions, which is why IBS consistently worsens under psychological stress. Mast Cells — The Immune Cells at the Heart of IBS Pain Mast cells are immune cells resident in the gut wall, particularly in the lamina propria. In healthy gut tissue, they respond to genuine threats. In IBS, mast cell density is elevated — and critically, mast cells are found in close proximity to the enteric nerve endings responsible for visceral sensation. When mast cells degranulate (release their inflammatory contents — histamine, tryptase, prostaglandins), they directly activate these nearby nerve endings, lowering the pain threshold and producing visceral hypersensitivity. Food antigens, psychological stress, bacterial LPS, and even specific foods (via IgE and IgG reactions) all trigger mast cell activation. This mast cell-nerve proximity is the primary anatomical basis for visceral hypersensitivity in IBS — the condition where the gut registers normal gas volumes or mild distension as painful.

Serotonin and the Gut — The Neurotransmitter Behind Motility and Pain The gut produces over 90% of the body's serotonin (5-HT) — manufactured by enterochromaffin cells in response to mechanical and chemical stimulation. Serotonin regulates virtually every aspect of gut motility: it triggers peristaltic contractions, controls secretion, and modulates visceral pain sensitivity. In IBS, serotonin signalling is dysregulated in distinct patterns: • IBS-D (diarrhoea-predominant): elevated serotonin release after eating, driving accelerated transit and urgency • IBS-C (constipation-predominant): reduced serotonin availability or receptor sensitivity, slowing motility• IBS-M (mixed): fluctuating serotonin states producing alternating transitGut dysbiosis compounds this — because specific gut bacteria are required for normal enterochromaffin cell serotonin synthesis. When the microbiome is disrupted, serotonin regulation becomes erratic, worsening both motility and pain amplification.

Steps

1. The Gut-Brain Axis in IBS — Why Stress, Anxiety, and IBS Always Appear Together
2. IBS and anxiety or depression co-occur at rates of 40–60% — far higher than chance. This isn't a coincidence, and it isn't purely psychological. It reflects the bidirectional nature of the gut-brain axis — the vagus nerve and enteric-CNS communication pathway.
3. Under chronic psychological stress, the HPA axis elevates cortisol, which:
4. • Directly loosens gut tight junctions (worsening permeability)
5. • Alters the gut microbiome composition within 48–72 hours
6. • Activates mast cells in the gut wall
7. • Shifts serotonin signalling toward a more excitable state
8. • Reduces the pain threshold of visceral afferent nerves Meanwhile, gut-derived signals — from dysbiotic bacteria, LPS, and inflammatory mediators — travel via the vagus nerve to the brain, activating anxiety centres and amplifying the HPA stress response. The brain and gut feed each other's dysfunction in a self-perpetuating cycle.

Related Resources

• Food Triggers in IBS — What the Gut Is Actually Reacting To
• Food sensitivity in IBS is not a true food allergy in most cases — it's a combination of fermentation-mediated gas production, immune-mediated mast cell activation, and motility changes specific to the individual's dysbiotic microbiome.
• FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) are the most validated dietary triggers in IBS. They are rapidly fermented by colonic bacteria, producing hydrogen and methane gas that distends the gut — triggering pain in viscerally hypersensitive guts. High-FODMAP foods include: onion, garlic, wheat, legumes, lactose, fructose (in apple, pear, mango), and artificial sweeteners.
• A low-FODMAP diet reduces IBS symptoms in 50–75% of patients in clinical trials — making it the most evidence-supported dietary intervention for IBS. Crucially, it is not a permanent diet but a diagnostic and temporary therapeutic tool — the long-term goal is restoring a microbiome capable of tolerating a wide dietary range.
• Histamine intolerance is another under-recognised IBS trigger — particularly in women with cyclical worsening linked to oestrogen (which stimulates histamine release and inhibits the diamine oxidase enzyme responsible for histamine breakdown).

Frequently Asked Questions

IBS and gut inflammation are not separate categories — they are two expressions of the same disrupted gut environment. The microbiome dysbiosis, increased intestinal permeability, mast cell activation, serotonin dysregulation, and gut–brain axis dysfunction that define IBS are all inflammatory processes, even if they do not produce the visible structural damage seen in more severe conditions. Understanding this changes how IBS recovery should be approached. It is not about managing isolated meals or suppressing individual symptoms. Instead, it requires restoring the internal gut environment — improving microbiome diversity, strengthening intestinal barrier integrity, regulating serotonin signalling, and stabilising the stress response. The gut is not overreacting. It is responding to an internal environment that needs to be restored from within. Image & ALT Text Suggestions 1. Gut Barrier Integrity - Image: Gut wall cross-section showing healthy tight junctions vs leaky gut - ALT Text: diagram showing leaky gut intestinal permeability as a root cause of IBS and gut inflammation 2. Mast Cell Activation - Image: Mast cells positioned near enteric nerve endings - ALT Text: illustration of mast cell degranulation triggering visceral hypersensitivity in IBS 3. Serotonin & Gut Motility - Image: Enterochromaffin cells producing serotonin (IBS-D vs IBS-C comparison) - ALT Text: diagram of gut serotonin production and its role in IBS diarrhoea and constipation motility 4. Gut–Brain Axis & Stress - Image: Stress response pathway showing cortisol impact on gut lining - ALT Text: infographic showing how chronic stress via HPA axis worsens IBS through gut-brain axis 5. FODMAP Fermentation - Image: High vs low FODMAP foods and fermentation effects in the gut - ALT Text: infographic showing high FODMAP foods that trigger IBS gas bloating and pain